As per attachment
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.4 pts less than Nifty Microcap 250 and 2.9 pts less than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Vipul Organics reported FY25 standalone revenue from operations of ₹16,280 lakhs, up 8.5% from ₹15,008 lakhs in FY24. Profit after tax jumped ~34% to ₹480 lakhs (₹358 lakhs in FY24), with basic EPS rising to ₹2.71 from ₹2.09. Q4 standalone revenue grew ~10% YoY to ₹4,409 lakhs, but Q4 PAT fell to ₹75 lakhs from ₹107 lakhs a year ago. The board has recommended a dividend of ₹0.80 per share (8%) subject to shareholder approval. The company also completed a Rights Issue of 42.37 lakh equity shares at ₹48 per share on April 8, 2025, and increased its authorised share capital to ₹20 crore. The auditor (J. A. Rajani & Co.) issued an unmodified opinion on both standalone and consolidated results.
Strong full-year profit growth and margin expansion are positives for shareholders, though the sharp Q4 PAT dip and weak operating cash flow (just ₹62 lakhs vs ₹486 lakhs in FY24) may raise concerns. The modest 8% dividend and fresh equity from the Rights Issue will dilute per-share metrics slightly, but the equity raise strengthens the balance sheet for future capacity expansion.